QQQ   419.63 (-0.89%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.75 (-0.19%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.99 (-1.28%)
CGC   7.72 (-1.40%)
DIS   111.81 (-0.55%)
AMC   3.12 (+6.85%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.18 (+1.40%)
QQQ   419.63 (-0.89%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.75 (-0.19%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.99 (-1.28%)
CGC   7.72 (-1.40%)
DIS   111.81 (-0.55%)
AMC   3.12 (+6.85%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.18 (+1.40%)
QQQ   419.63 (-0.89%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.75 (-0.19%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.99 (-1.28%)
CGC   7.72 (-1.40%)
DIS   111.81 (-0.55%)
AMC   3.12 (+6.85%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.18 (+1.40%)
QQQ   419.63 (-0.89%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.75 (-0.19%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.99 (-1.28%)
CGC   7.72 (-1.40%)
DIS   111.81 (-0.55%)
AMC   3.12 (+6.85%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.18 (+1.40%)
Free Trial

Nuvectis Pharma (NVCT) SEC Filings & 10K Form

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)
Free NVCT Stock Alerts
$6.78
+0.06 (+0.89%)
(As of 10:53 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Recent Nuvectis Pharma SEC Filings

Export to Excel
DateFilerForm TypeView
03/19/2024
7:00 AM		BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
4:20 PM		Nuvectis Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2024
7:17 AM		Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
7:37 AM		Mosseri Marlio Charles (Filed by)
Nuvectis Pharma (Subject)
Form SC 13G/A
02/06/2024
7:47 AM		Nuvectis Pharma (Subject)
Pontifax Management 4 G.P. Ltd. (0001726334) (Filed by)
Form SC 13G
01/30/2024
8:01 PM		Nuvectis Pharma (Subject)
Peters Thomas Phineas (Filed by)
Form SC 13G/A
01/05/2024
3:30 PM		Nuvectis Pharma (Issuer)
Shemesh Shay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:31 PM		Nuvectis Pharma (Issuer)
Poradosu Enrique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
7:39 AM		Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
6:45 AM		Nuvectis Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/12/2023
3:05 PM		BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
7:30 AM		BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
7:37 AM		BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
7:16 AM		Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2023
8:18 AM		Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2023
5:07 PM		BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2023
7:00 AM		Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2023
7:00 AM		Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2023
7:00 AM		Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/27/2023
5:52 AM		Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
3:45 PM		Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
3:45 PM		BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
5:30 AM		BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
5:30 AM		Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2023
7:06 AM		Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
7:34 AM		BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2023
7:30 AM		Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
7:30 AM		Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2023
7:00 AM		Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
7:03 AM		BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
7:04 AM		Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
6:45 AM		Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
7:00 AM		Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2023
7:45 AM		BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
7:45 AM		Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
7:45 AM		Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
7:59 AM		Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
7:42 AM		BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
7:25 AM		Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
7:15 AM		Hoberman Kenneth (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
7:16 AM		Kaplan Matthew L. (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.
06/20/2023
7:16 AM		Nuvectis Pharma (Issuer)
Oliviero James F III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
3:45 PM		Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
5:46 AM		Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
8:28 PM		BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2023
7:00 AM		BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
8:29 AM		BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2023
6:00 AM		BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
7:22 AM		Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2023
3:30 PM		Nuvectis Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2023
8:25 AM		Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:NVCT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Urgent alert: open this for a huge profit potential
Timothy Sykes